I'm JC Ruffalo, a General Partner at Cove Fund IV and a Partner at Cove Fund III, where I've backed early-stage founders across Southern California since 2021.
Before Cove, I built and ran the LaunchPad accelerator at Octane OC from 2014 to 2022, working hands-on with founders whose companies have since raised more than $2.4B and produced multiple IPOs and acquisitions. My path went from entrepreneur to accelerator director to investor, and that operator's lens still shapes how I work.
I like getting in early with technical founders building real products in enterprise software, healthcare technology, and frontier systems, then staying close as they grow.
What connects all of it is a simple belief: the best companies are built on relationships, not transactions. I've spent more than a decade in the Southern California startup community, first as a founder, then running an accelerator, and now as an investor, and the pattern has never changed. I look for talented technical people early, earn their trust, and stay in their corner as they grow. I pay as much attention to how founders think and treat their teams as I do to the market they're chasing, and I'd rather know someone for years before backing them than win a deal on speed alone. Helping builders turn an idea into something real is the part of this work I care about most.
| Company | Sector | First Inv. | Invested | Status | Notes / Outcome |
|---|---|---|---|---|---|
| Content.One (Zesty.io)Content management & web platform | SaaS / MarTech | 11/2021 | $500K | Active · 1.26x | Note + equity · $2.3M ARR · marked at ~$632K · potential M&A path |
| iCardioAI-powered cardiac imaging | HealthTech / AI | 3/2026 | $500K | Active · New | Series Seed · March 2026 · held at cost |
| 3Laws RoboticsCalTech robotics safety software | Deep Tech / AI | 9/2024 | $500K | Amazon Acquisition | ~1.8x · ~41% IRR · closed Q2 2026 |
| XiloInsurance quoting & sales automation | InsurTech / SaaS | 8/2022 | $770K | Portfolio Leader · 1.39x | $5.5M ARR ($600K ahead of plan) · 130% NRR · Brown & Brown closed Feb · AI Quoting Agent launched · path to $10M ARR → Series B |
| Carro / VYRLCollaborative commerce / dropship | eCommerce / B2B | 9/2025 | $750K | Breakout · $1B GMV | $6.8M → $105.6M GMV · 149x growth in 18 mo · profitable · on track for $1B/yr run-rate July 2026 |
| BLNGJewelry intelligence platform · B2B SaaS | eCommerce / AI | 2/2025 | $300K | Breakout Quarter | David Yurman $1M/yr (largest enterprise deal) · Tiffany in final negotiations · Rolex pilot · Signet sole-vendor (2,000-store) · Seed II co-led by Cove & SpeedInvest |
| Quantum ElementsQuantum digital twin software | Deep Tech / Quantum | 3/2026 | $750K | Technical + Commercial Breakout | World's largest hardware-faithful quantum digital twin w/ AWS · Nature Comms paper · SAFE oversubscribed $2.8M · 49-month runway |
| SigmaSightLitigation intelligence · B2B SaaS | LegalTech / AI | 12/2024 | $1.3M | Strong Traction | $500K ARR (Mitsui) · enterprise contract signed · Series A prep |
| OccuspaceSpace utilization analytics | PropTech / AI | 8/2023 | $850K | Portfolio Leader · 1.36x | $3.33M CARR (+52% YoY) · 5-yr $41.9M GSA contract active · Notre Dame, LSU & Kaiser wins · bridging to Q3 '27 breakeven |
| VisaicImmersive fan experience platform | Media / Sports Tech | 5/2024 | $600K | Strong Growth | $1.5M gross revenue (+63% YoY) · MidCo Sports signed Jan (largest customer) · Black Bear early 5-yr renewal |
| VECKTAEnergy transition marketplace | ClimateTech / Marketplace | 6/2022 | $825K | Series A Signed | 2.3x pro forma · Series A signed, pending close |
| Eira BioOncology & women's health therapeutics | BioTech / Oncology | 11/2025 | $250K | Solid Execution | Lead prostate cancer program on track for dev candidate by year-end · preeclampsia program advancing · 16 FTEs · on budget |
| MelioCulture-free blood pathogen detection | MedTech / Diagnostics | 5/2024 | $500K | Fundraising | $3.5M CARBEX grant · Series A in market |
| Time MachineAI onboarding & training for sales teams | AI / B2B SaaS | 9/2025 | $500K | Active | $300K ARR · 30 customers · Series A prep |
| CelitechWhite-label eSIM for travel operators | TelecomTech / B2B2C | 6/2022 | $625K | Active | Cove-led seed · Series A prep |
| CenfireFabless semiconductor · MEMS relay tech | Semiconductors / Deep Tech | 1/2026 | $500K | Seed-2 | Silicon MEMS relay tech (no metal fatigue) · $3.3M Seed-2 at $10.9M pre · initial market T&M/ATE · ~$15B SAM |
| WethosFreelancer team-building & pricing | Future of Work / SaaS | 7/2024 | $500K | Fundraising | Raising $20M+ Series A at $100M+ valuation |
| ExokeryxExtracellular vesicle extraction | BioTech / Diagnostics | 7/2024 | $500K | Watch — Tight Timeline | First product revenue · cash through September · hiring frozen · Series A on hold pending revenue |
| CARI HealthReal-time medication monitoring | HealthTech | 7/2022 | $500K | Written Down 50% | Pivot in progress · bridge underway |
| GroGuruPrecision agriculture soil intelligence | AgTech | 6/2023 | $600K | Written Off | $100K secured note repaid |
| Company | Val. at LaunchPad | Latest Post-Money | Val. Growth | Outcome |
|---|---|---|---|---|
| DTx PharmaRNA therapeutics · San Diego | $6M | $1.10B (Novartis acq.) | 183.3x | Acquired · Novartis |
| HypericeRecovery tech · Irvine, CA | $8M | $850M (Series B) | 106.3x | Active · Series B |
| AcornsConsumer fintech | $9M | $870M | 96.7x | Active |
| SentryCardPayment security fintech | $12M | $150M | 12.5x | Active |
| Neural AnalyticsBrain health diagnostics | $7.7M | $93M | 12.1x | Active |
| NGD SystemsStorage semiconductor | $22.6M | $106M | 4.7x | Active |
| SonendoDental MedTech | $74.3M | $500M+ | 6.7x+ | IPO · NYSE: SONX |
| RxSightAdjustable intraocular lenses · Aliso Viejo, CA | n/a | n/a | n/a | IPO · Nasdaq: RXST |
| LensGenOphthalmology devices | $19.2M | $76.2M | 4.0x | Active |
| Recros MedicaWound care / injectables | $20M | $45M | 2.3x | Active |
| MavenlinkPSA software | $61.4M | $235M | 3.8x | Merged · Kantata |
| BontiBotulinum toxin biotech | $22.3M | $195M | 8.8x | Acquired · Allergan |
| EnevateEV battery technology | $44.1M | $251M | 5.7x | Active |
Deal flow is driven by a network spanning key innovation hubs, built through years operating at the center of founder, university, and investor ecosystems. Rooted in Southern California but national in reach, surfacing high-potential companies before they become broadly visible.
At the seed stage, outcomes are driven by a small number of breakout companies. The strategy identifies these early, supported by a decade of pattern recognition and data-backed selection, then concentrates time, conviction, and follow-on capital behind the strongest positions.
We partner closely with founders through the most critical stages of company formation and early growth — strategic positioning and narrative, customer and investor introductions, and navigating the Seed → Series A transition.